A father-and-son team, built on published evidence
Pureline Biolabs Ltd (Company No. 17236739) is operated by Chris and Daniel, based in England. We entered this industry following published scientific literature on synthetic reference peptides and analytical methodology—specifically observing the persistent gap between what a Certificate of Analysis (COA) claims and what it actually demonstrates.
When we evaluated research peptides in the UK, documentation was the primary vulnerability:
- Purity figures quoted with no analytical method attached.
- Certificates naming no accredited issuing laboratory.
- Vial contents stated as a fill target rather than a measured active mass.
So we established the research chemical supplier we wished existed: one where every batch is independently tested before listing, the testing laboratory is named, and every result can be verified independently by the researcher.
“When independent Janoshik testing of an early supplier’s samples came back with zero active peptide, we knew third-party verification wasn’t optional. It was the entire foundation of our business.”
— CHRIS & DANIEL, PURELINE BIOLABSWhy analytical documentation matters more than market claims
The research peptide market faces a verification challenge rather than a trust issue. Our framework is transparent and audit-ready: publish the certificate before stock is listed, name the testing laboratory, and state the measured content alongside the labelled mass (including where measured quantities fall below nominal target).
Unverifiable Certificates
Many purity reports are published without assay methodology, laboratory identification, or batch references, leaving researchers with no verification path.
Unmonitored Cold Chain
Peptides are temperature-sensitive compounds. Transport without continuous refrigeration or thermal gel packaging compromises structural integrity regardless of initial purity.
Lack of Independent Testing
Manufacturer-provided self-testing does not constitute independent verification. Janoshik Analytical provides objective third-party HPLC purity and LC-MS identity analysis for every lot.
Frequently Asked Questions
Who runs Pureline Biolabs?
Pureline Biolabs Ltd is operated by Chris and Daniel, a father-and-son team based in England. The company is registered in England & Wales (Company No. 17236739).
Where are your research peptides tested?
Every batch undergoes independent third-party analysis at Janoshik Analytical in Prague using High-Performance Liquid Chromatography (HPLC) for purity and Mass Spectrometry (LC-MS) for identity. Each certificate is hosted directly on Janoshik’s verification portal.
What purity standards do your products meet?
Every batch must test at or above 98% HPLC purity prior to release. Batches below this threshold are permanently rejected. Our current inventory averages 99.20% chromatographic purity.
How is stock stored and shipped?
Inventory is maintained continuously at 2–8°C in pharmaceutical-grade refrigeration. Orders are dispatched in insulated packaging with refrigerant gel packs. Orders confirmed before 14:00 (Monday–Friday) are dispatched same-day via tracked UK domestic delivery.
Do you provide compound handling or usage advice?
No. All compounds are supplied strictly for in vitro laboratory research, chemical analysis, and method development. We do not provide administration protocols, reconstitution guidance, or clinical/therapeutic advice of any kind.